|
|
||||||||



* Institut National de la Santé et de la Recherche Médicale, U591, Paris, France;
Université Paris Descartes, Institut Fédératif de Recherche 94 Necker-Enfants Malades; and
Centre National de la Recherche Scientifique Unité Mixte de Recherche 8147, Hôpital Necker, Paris, France
| Abstract |
|---|
|
|
|---|
–/–, CD3
–/–, and nude mice, and absent in IL-7- and Rag-2-deficient mice. Neither B nor myeloid cells are generated in vivo and in vitro. The incidence of these pre-T cells is under the control of thymus and/or mature T cells, as revealed by graft experiments. Indeed, IL-7 consumption by mature T cells inhibits the growth of these pre-T cells. Moreover, the nude spleen contains an additional Lin–Thy1.2+CD25+ subset which is detected in B6 mice only after thymectomy. We establish that the full pre-T cell potential and proliferation capacity are only present in the c-kitlow fraction of progenitors. We also show that most CCR9+ progenitors are retained in the spleen of nude mice, but present in the blood of B6 mice. Thus, our data describe a new T cell lineage restricted subset that accumulates in the spleen before migration to the thymus. | Introduction |
|---|
|
|
|---|
–/– mice (that contains only 2% of DN cells) is restored to normal cellularity after intrathymic (i.t.) transfer of wild-type (wt) BM cells. In contrast, the thymus of Rag-2–/– mice (composed exclusively of DN cells) is weakly reconstituted under the same conditions. Moreover, according to a recent report, interaction between P-selectin (expressed by thymic endothelium) and its ligand PSGL-1 (expressed on lymphoid progenitors) facilitates engraftment of T cell progenitors in the thymus (3). The authors therefore suggested that P-selectin expression is regulated by the number of i.t. progenitors. Thus, active signals are probably required for efficient thymus seeding by T cell progenitors. It is also possible that circulating progenitors have to reach a critical level and/or a specific maturation stage before they can enter the thymus. The identity of the progenitors (both in terms of phenotype and differentiation stage) which home to the thymus is still subject to intense debate, explaining why the list of potential candidates has grown steadily in recent years.
Progenitors with predominantly T cell potential (but also associated with B, NK, and myeloid activities) have been identified in mouse BM and blood. They belong to the Lin–Sca-1+ c-kit+ (LSK) subset and express additional, specific Ags: Flt3+CD27+ IL-7R
+/– for the earliest lymphoid progenitors (4); Thy1.1–CD62L+ for LSK CD62L+ precursors (thought to represent the last stage of differentiation in the BM before thymus colonization (5, 6)); and VCAM-1+ for the multipotent progenitor subset reported recently by Kondo and colleagues (7). The common lymphoid progenitors (CLPs) (Lin–Sca-1low c-kitlow IL-7R
+) (8) are restricted to the lymphoid lineage, mainly engaged in B cell development (9) and, therefore, probably do not contribute to thymus colonization. However, this point has been recently challenged; in vitro, CLPs are able to quickly adopt a DN2 phenotype, suggesting that this population could indeed colonize the thymus after a BM transplant (10). Thus, it is still not clear whether the T cell progenitors described above belong to a common differentiation pathway or follow distinct maturation routes. Whatever the answer, it is clear that very few cells are needed for thymus colonization. Rather than attempting to trace these cells directly, one way to learn more about the identity of this minute population is to explore how T cell progenitors are regulated.
A progenitor having recently seeded the thymus probably belongs to the earliest T cell progenitor (ETP) c-kithigh IL-7R
– DN1 population (11) and resembles the CCR9high subset described by Benz and Bleul (12). In CCR9-GFP knockin mice, CCR9high ETP multipotent cells (present in the BM and the blood) generate a CCR9low population, which completely lacks B cell potential in the thymus. Thus, the CCR9high ETP subset is considered as the colonizing population.
To date, several studies have provided evidence of extrathymic pre-T cells. A Lin–Thy1.2highCD44+CD25– fully committed T cell population (CTP) was described in the BM of B6 mice (13, 14); following i.v. transfer to athymic nude mice, this CTP was able to generate T cells via an extrathymic pathway (15). Recently, a pre-T population has been characterized in the blood of pre-TCR
/hu CD25 Tg mice. Its phenotype is similar to that of the BM CTP described by Strober and colleagues, suggesting that the two populations might belong to the same pathway (16). In gut cryptopatches, Lin–Thy1+IL-7R
+CD25+ cells have been identified as precursors of intraepithelial lymphocytes (IELs) (17). Furthermore, we have reported a Lin–Thy1+CD44–CD25+ pre-T cell population in colonies formed in the spleen of lethally irradiated mice 12 days after BM transfer, referred to as "SC12" colonies (18). We established that this T cell-restricted population did not depend on the presence of the thymus (19).
Hence, having identified a pre-T cell population in SC12, we sought to determine whether a similar population was present in the spleen of nonmanipulated mice. In this study, we report on the identification and regulation of a T cell lineage-committed Lin–Thy1.2+ population that accumulates in the spleen. This subset is under the control of the thymus and/or mature T cells that may regulate the availability of the IL-7 needed for progenitor generation.
| Materials and Methods |
|---|
|
|
|---|
All mice were bred on a pure C57BL/6 (B6) genetic background. Ly5.1 mice and Ly5.1 CD3
–/– mice were purchased from Transgenic Alliance and Centre de Distribution, Typage, Archivage Animal. Ly5.2 mice were purchased from Centre dElevage R. Janvier and nude (nu/nu) mice were bought from Centre de Distribution or Taconic. C57BL/Ba (Ba), IL-7–/–, Ly5.1 Rag-2–/–, and Ly5.1 Rag-2–/–
c–/– mice were bred and maintained in the animal care facility in the Necker Institute.
Thymectomy and mature T cell grafts
Mice were thymectomized (Tx) between 4 and 12 wk before analysis, as described elsewhere (18). In brief, mice were anesthetized and placed on their back; an incision was made in the skin above the sternum and the thymus was removed with forceps. The skin was closed with metal surgical clips. The completeness of thymectomy was confirmed at autopsy. Animal experiments were approved by our institutional animal care and use committee.
Lymph node (LN) and/or spleen cells were recovered from Ba (Thy1.1, Ly5.2), B6 (Thy1.2, Ly5.2), or IL-7R
–/– (Thy1.2, Ly5.2) mice, as appropriate. T cells (2 x 106) were i.v. injected into nude or Ly5.1 CD3
–/– mice (Thy1.2). The number of donor-type cells was estimated in the LNs, spleen, and BM 5, 30, and 60 days after transfer. The host spleen was analyzed for the presence of Lin–Thy1.2+ progenitors.
Antibodies, flow cytometry, and cell sorting
The following mAbs used for cytometry and/or cell sorting were obtained from BD Pharmingen: anti-CD2 (LFA-2, RM2–5), anti-CD3 (145-2C11), anti-CD4 (RM4–5), anti-CD8
(53-6.7), anti-CD8β (H35–172), anti-CD11a/
L (2D7), anti-CD11b/Mac-1 (M1/70), anti-CD16/CD32 (Fc
II/IIIR, 24G2), anti-CD18/β2 (C71/16), anti-CD19 (1D3), anti-CD25 (IL-2R
, PC61), anti-CD29/β1 (Ha2/5), anti-CD44 (H-CAM, 1M781), anti-CD45.2/Ly5.2 (104-2.1), anti-CD49d/
4 (R1–2), anti-CD49e/
5 (5H10–27), anti-CD62L (L-selectin, Mel14), anti-CD90.2/Thy1.2 (53.2.1), anti-CD117/c-kit (stem cell factor receptor, 2B8), anti-CD127/IL-7R
(A7R34, a gift from Dr. S.-I. Nishikawa, Kyoto University and RIKEN Center, Kyoto, Japan), anti-CD162/PSGL-1 (2PH1), anti-NK1.1 (PK136), anti-Sca-1 (stem cell Ag-1, E13–161.7), anti-erythroid (TER119), anti-Ly-6G/Gr1 (RB6–8C5), anti-LPAM-1/
4β7 (DATK/32), anti-TCRβ (HAM or H57–597), and anti-TCR
(GL3). The anti-IgM and the anti-CD45.1/Ly5.1 (A20-7.1) mAbs were obtained from Southern Biotech. The anti-CDw199/CCR9 (242503) mAb was obtained from R&D Systems. All the above-mentioned mAbs were directly coupled to FITC, allophycocyanin, PE, and PerCP, or conjugated with biotin (the latter being revealed by streptavidin-allophycocyanin or streptavidin-PECy7; BD Pharmingen). A FACSCalibur (BD Biosciences) was used for flow cytometry, whereas cell sorting was performed on a FACSVantage upgraded with DIVA software (BD Biosciences). Data were analyzed using CellQuest and CellQuestPro software packages (BD Biosciences).
For cell sorting, spleen cells were first incubated with unconjugated TER119 and Ly-6G/Gr1 (RB6–8C5) rat mAb, which are specific for erythroid and myeloid cells, respectively. Positive cells were magnetically depleted with sheep anti-rat IgG-conjugated beads and sheep anti-mouse IgG-conjugated beads (Dynabeads M-450; Dynal Biotech). The remaining cells were labeled with Abs against the Ly5.2, Thy1.2, and lineage Ags (CD3, CD19, Mac-1, NK1.1, and TCRβ). For analysis of triple-negative (TN) CD3–CD4–CD8– cells in the thymus, cell suspensions were first incubated with unconjugated TER119, CD5 (53-7.3), and CD8
(LyT2) rat Abs. Positive cells were removed magnetically with sheep anti-rat IgG-conjugated beads (Dynabeads M-450; Dynal Biotech) and the negative fraction was labeled with Abs against CD25, CD44, and lineage Ags (Mac-1, 8C5, NK1.1, TCRβ, TCR
, CD8β, and CD19).
In vivo transfer of precursor cells
Recipient mice were sublethally irradiated (600 rad) and test cells were injected i.t. or i.v., as described in detail elsewhere (18). In brief, 4 x 104 precursor cells were resuspended in 200 µl of medium for i.v. injection into Ly5.1 Rag-2–/– mice, whereas 2 x 104 precursor cells in 20 µl were directly transferred into the thymic lobe of Ly5.1 B6 recipients. One or two months after i.v. injection, Ly5.2+ donor cells were recovered from the LNs, spleen, BM, and thymus of recipient mice. LN cells were pooled from axillary, inguinal, and mesenteric sites, which are thought to represent approximately half the bodys total lymph node mass (20). For the evaluation of medullary reconstitution, two femurs plus two tibias were considered to represent 25% of the total BM (21). Consequently, the size of the T cell pool was calculated according to the following formula: 2 x LN + 1 x spleen + 4 x BM (LN, number of donor T cells collected in lymph nodes; spleen, number of donor T cells collected in the spleen; BM, number of donor T cells collected in the bone marrow). The numbers of B, NK, and myeloid cells were calculated according to the following formula: 1 x spleen + 4 x BM.
In vitro cultures
In vitro cultures were maintained on the OP9 and OP9-DL1 stromal cell lines described by Schmitt and Zùñiga-Pflucker (22). The OP9-DL4 stroma was a gift from Dr. A. Cumano (Pasteur Institute, Paris, France). In brief, stromal cells lines were seeded into 24-well tissue culture plates before coculture with progenitors. All cultures were performed in the presence of 1 ng/ml IL-7 (R&D Systems) and 5 ng/ml Flt-3L (R&D Systems) and fed every 4 days. At the indicated time, progenitor cells were recovered and stained to detect B cells (CD19), T cells (CD4/CD8/TCR
β), NK cells (NK1.1/TCR
β), and myeloid cells (Mac-1). A propidium iodide exclusion assay was used to screen out dead cells.
| Results |
|---|
|
|
|---|
We have previously described a phenotype that defines committed T cell progenitors in the spleen after a BM graft: Lin–Thy1.2+ CD25+ (18, 19). Based on these findings, we sought to establish whether or not this population is present in unmanipulated wt B6 mice. We analyzed the lineage negative (Lin–) compartment of spleen cells by using appropriate markers (Mac-1, NK1.1, CD3
, TCRβ, CD19, and TER119) to exclude mature cells and to identify the progenitor population. The Lin– population represented 0.34 ± 0.19% (n = 9) of the total spleen cells in B6 mice and could be divided into a major Thy1.2– subset (92.2 ± 3.7% (n = 9)) and a minor Thy1.2+ (7.8 ± 3.7% (n = 9)) subset (Fig. 1A). Lin– Thy1.2+ populations were also present in the BM and the blood (Fig. 1A), although expression of the CD25+ subset varied; in the BM, most Thy1.2+ cells were CD25+ but these were far more rare in the blood and the spleen.
|
1.0 ± 0.5% (n = 9) of the total spleen cells and was significantly higher than in B6 mice (t test, p < 0.005) (Fig. 1A). Most spleen cells belonged to the Lin–Thy1.2– subset, whereas Thy1.2+ cells constituted 18.9 ± 6.8% (n = 9) of the Lin– cells in 4- to 12-wk-old nude mice (Fig. 1A) This last value reached 39.0 ± 7% (n = 6) in older mice and was statistically different than younger mice (t test, p < 0.002). The BM and blood profiles looked similar to those observed in B6 mice (Fig. 1A). However, we were able to detect an increased CD25+ subset in the spleen.
Hence, our results show that the Lin–Thy1.2+ population we identified in the spleen was more abundant in the nude mouse and, when compared with the B6 mouse, contained a prominent CD25+ subset. We then focused on defining how this population was represented in various immunodeficient mouse strains. Data from CD3
–/–, TCR
–/–, Rag-2–/–, Rag-2–/–
c–/–, and IL-7–/– mice are presented in Fig. 1B. They revealed that the Thy1.2+ population was rare in Rag-2–/– mice and absent in IL-7–/– and Rag-2–/–
c–/– mice, suggesting that the Rag machinery and IL-7 are important for maintenance of this population. The high number of pre-T cells in CD3
–/– mice, compared with Rag-2–/– mice, suggested that, probably, TCRβ-rearranged subsets exist among the Lin–Thy1.2+ population whose survival/proliferative signals are unclear and will have to be defined. Most extrathymic pre-T cells described by us and others present some TCRβ rearrangements: Thy1+ c-kitlow cells in the fetal blood (23), CTP in the BM (13), and SC12 (18). Moreover, one cannot exclude that the presence of mature B cells plays a major role in shaping the environment of the spleen in CD3
–/– mice. In contrast, CD3
–/– and TCR
–/– mice contained abundant Lin–Thy1.2+ cells (Fig. 1B), as did nude mice. The highest number of progenitors in TCR
–/– mice is most probably due to the production of IL-7 in the thymus. Indeed, these mice differentiate until the double-positive (DP) stage (in contrast to CD3
–/– mice) and therefore, the thymic epithelium is stimulated to produce IL-7 (24, 25). However, with age, IL-7 production is decreased (26). Thus, less cytokine is available in periphery, reducing the number of progenitors in the spleen of TCR
–/– mice (Fig. 1B). Thus, the Lin–Thy1.2+ population was best represented in T cell-deficient mice and rare in B6 animals.
To further characterize these splenic Lin– Thy1.2+ populations, we phenotyped them and compared the profiles obtained in B6 and nude mice with those from specific hemopoietic subsets (Fig. 2). Most progenitors expressed CD44 in B6 and nude mice. However, expression of IL-7R
was mainly limited to the Thy1.2+ progenitor pool. Only the CLP expresses this receptor and clearly shows a T-B bias (8); it differs in this regard from the LSK population in the BM, which does not express the IL-7R
-chain. This finding argues in favor of a lymphoid commitment (6). In contrast, c-kit expression revealed a difference between nude and B6 progenitors:
10% of the rare Lin–Thy1.2+ B6 spleen cells were c-kitlow, whereas >65% of nude Thy1.2+ progenitors were c-kitlow cells. The two candidate populations for thymus-homing (the CLP and the LSK) expressed c-kit with variable intensity (6, 8) and only the CLP was seen to be c-kitlow, thus suggesting that nude progenitors might have lymphoid potential. Moreover, c-kit down-regulation has been described as corresponding to hemopoietic stem cell differentiation and progression to the lymphoid lineage (27). In terms of Sca-1 expression, most nude Thy1.2+ progenitors were Sca-1+, whereas this characteristic was less represented in B6 progenitors. Another discrepancy between nude and B6 Thy1.2+ progenitors concerned CD2 expression, which was rare for most nude progenitors. This finding was also reported for a BM pre-T population (13). Thus, most B6 progenitors were CD44+IL-7R
+ c-kit– CD2+/–Sca-1+/–, whereas nude progenitors differed in terms of c-kit and Sca-1 expression and were mostly CD2–.
|
Absence of myeloid and B cell potentials among Lin– Thy1.2+ progenitors
Phenotype characterization revealed that Lin– Thy1.2+ progenitors resembled committed lymphoid progenitors, rather than LSKs. Hence, we examined the potential of B6 and nude splenic progenitors by transferring them i.t. (2 x 104 cells) or i.v. (4 x 104 cells) to appropriate recipients.
Nude Lin–Thy1.2+ progenitors grafted in the thymus generated progeny from day 8 onwards, as did the Lin–Thy1.2– progenitor population (Fig. 3A). At this time point, the progeny of the Thy1.2+ population had reached the CD4+CD8+ (DP) stage of differentiation—unlike the Thy1.2– cells, which mostly remained CD4–CD8– (DN) (data not shown). The respective changes over time in the progenitor populations were quite different. By day 12–13, DP cells were abundant and SP cells were detected among the progeny of Lin–Thy1.2+ cells; few TCR
+ cells were present within the CD4–CD8– window (data not shown); at day 25, the DP pool was exhausted and CD4+ or CD8+TCR
β+ (SP) cells constituted the majority of donor cells in the thymus. In contrast, T cell differentiation of the Lin–Thy1.2– subset was much slower, because a high percentage of DP cells was still present at day 30 and thus indicated the persistence of progenitors (data not shown). Indeed, the Thy1.2+ subset generated the most cells between days 12 and 15 postgraft and declined thereafter, whereas the Thy1.2– progeny continued to increase (Fig. 3A). One can therefore conclude that the Lin– Thy1.2+ subset is more enriched in T cell progenitors than the Thy1.2– subset and engendered a shorter wave of thymic repopulation, which is indicative of a pre-T cell-enriched population with limited renewal potential. We tested this hypothesis by assessing the full hemopoietic differentiation potential of these subsets.
|
βhigh T cells were recovered in peripheral compartments, such as spleen (Fig. 3B), LN (data not shown), and BM (data not shown). In Lin–Thy1.2+-recipient mice, no B, myeloid, or NK cells were detected, whereas the Thy1.2– population generated T cells as well as B, NK, and myeloid cells (Fig. 3B). The data in Table I show that in the five grafted mice, Thy1.2– cells gave rise mainly to T and myeloid cells 1 mo and 2 mo later (Table I). In contrast, the Thy1.2+ population from nude mice essentially generated T cells; very few NK cells were detected in the BM only 1 mo after transfer (Table I). These data demonstrate that the nude Lin–Thy1.2+ population is T cell committed, whereas the Lin–Thy1.2– subset is multipotent. Similar studies were performed on splenic B6 Lin– progenitors (Table II), showing that NK and T cells derived from Lin– Thy1.2+ B6 progenitors and that the Thy1.2– population is multipotent. We noticed that the T cell pool was greater when nude splenic T cell precursors were grafted compared with B6 precursors (Tables I and II). These populations were extracted from different environments, and despite similar phenotype, they must maintain functional heterogeneity.
|
|
–/–Ly5.1 mice were grafted. When the multipotent Thy1.2– progenitor population was grafted in these conditions, only B and myeloid cells were generated in the spleen (Fig. 3C). In contrast, with Thy1.2+ progenitors, no donor-type cells (other than IELs) were detected in the six mice analyzed. In comparison with the IEL populations found in a B6 control mouse, Lin– Thy1.2+ progenitors generated mainly CD8
+ TCR
+ cells (Fig. 3C). Therefore, it appears that the T cell-committed population needs to colonize the thymus before fully differentiating into mature TCR
β+ T cells. The identified splenic pre-T cells were compared with thymic TN3 pre-T cells in terms of growth and differentiation. Fig. 4A shows that like thymic progenitors, Thy1.2+ splenic pre-T cells did not develop on an OP9 stroma; in contrast, the multipotent Lin–Thy1.2– subset developed better. Fig. 4B confirmed the in vivo data, because neither B nor myeloid cells were generated by nude and B6 Thy1.2+ progenitors on the OP9 stroma; in contrast, NK 1.1+ cells emerged within 2 weeks of culture, increased in percentage and persisted throughout the entire culture period in cultures of nude and B6 progenitors (Fig. 4B). We noted that B6 Thy1.2+ progenitors generated more NK cells than did nude cells.
|
3 wk in B6 and nude cultures (Fig. 4B); this suggests that NK potentiality is repressed by Notch signaling, as reported by others (28). Thus, like its B6 counterpart, the nude Lin–Thy1.2+ population lacks B and myeloid potential. Apart from their common pre-T potential, both pre-T populations are differentially represented in the spleen (with five times fewer progenitors in B6 (0.03 x 106 ± 0.02 (n = 9)), compared with nude spleen (0.15 x 106 ± 0.09 (n = 9)), t test, p < 0.005), suggesting that they might develop under the pressure of distinct and as yet undefined microenvironments.
T lineage-restricted potential in the nude spleen
Given that the Thy1.2+ population retained a weak NK potential, we decided to purify this subset. Further stainings revealed that CD25+ cells were almost all CD44+ CD2– and mainly c-kitlow (Fig. 5A).
|
Phenotypic analysis within the Lin–Thy1.2+ subset of B6 mice revealed that wt mice presented the same CD25/c-kit profile as nude mice:
60% of CD25+ cells were c-kitlow, whereas few CD25– cells expressed the c-kit Ag (Fig. 5C). However, sufficient numbers of these precursors were not available in the spleen of B6 mice to realize such cultures.
In the absence of a thymus, the pre-T population accumulates in the spleen
Our data had confirmed that the nude spleen can maintain pre-T cells within the CD25+ c-kitlow subset. However, this subset is rare in B6 spleen, suggesting that the presence of a competent thymus hampered the generation and/or expansion of this subset. To investigate the role of the thymus, we analyzed the spleen of B6 mice 2 to 3 mo after thymectomy. Fig. 6A reveals that the absolute number of Lin–Thy1.2+ CD25+ cells was significantly greater in Tx mice (7 x 103 ± 2 x 103 (n = 10)) than in normal B6 controls (3 x 103 ± 0.3 (n = 5)) (t test, p < 0.05). Hence, the thymus might directly or indirectly control the emergence of the CD25+ progenitor subset. This role could potentially be attributed to thymic progenitors or mature T cells. Nevertheless, we cannot exclude the possibility that the CD25+ subset accumulates in the spleen if it is unable to seed the thymus.
|
Analysis of mutant and Tx mice had suggested that the thymus and/or mature T cells might exert negative feedback on the Lin– Thy1.2+ population (Figs. 1B and 6A). To test this hypothesis, we injected around 2 x 106 T cells i.v. into Ly5.1 CD3
–/– mice and recovered their spleen 5, 30, or 60 days later. To establish whether IL-7 had a role in the process, a set of mice was grafted with IL-7R
–/– T cells. In the T cell-deficient host, mature adoptively transferred T cells underwent an expansion phase during the first 5 days and reached a plateau thereafter. Indeed, donor-type T cells represented between 2 and 10% of the spleen cell population during the study (data not shown). Furthermore, the number of Lin– cells in the spleen was greater in reconstituted mice than in uninjected controls (data not shown). The three independent experiments are reported in Fig. 6, B and C. Fig. 6B represents the ratio of Lin– Thy1.2+ to Lin–Thy1.2– cell numbers at different time points after grafting mature T cells sourced from normal B6 mice or IL-7R
–/– mice. Our data show that this ratio decreased in CD3
–/– recipients of normal T cells, relative to control mice and recipients of IL-7R
–/– T cells (t test, p < 0.05). This reduction was also observed in terms of absolute cell numbers and was significant at 60 days (t test, p < 0.05) (Fig. 6C). However, the reduction was not complete and stabilized at the level of pre-T cells found in unmanipulated B6 mice. Hence, mature T cells do inhibit the generation of pre-T cells in the spleen; this inhibition is driven by IL-7 consumption by mature T cells, so pre-T cells can accumulate in the absence of mature T cells.
Adhesion molecule expression on pre-T cells from the spleen
In principle, the pre-T population depicted in the spleen should also be specified by its integrin, selectin, and chemokine receptor expression. These molecules (involved in cell migration through tissues) have been well defined for i.t. progenitors (29) and are sequentially and specifically expressed at defined stages of i.t. differentiation. However, the entry of progenitors into the thymus is not well characterized and it is only recently that a few mechanisms have been suggested. Thymus homing seems to be mediated in three steps: 1) cell rolling by P-selectin/PSGL-1 interaction; 2) activation of
4β1 and
Lβ2 integrins, which is partially dependent on signaling through CCL25/CCR9; 3) firm adhesion via these latter integrins (3, 30). We therefore analyzed cell surface expression of
4 (integrin, CD49d),
5 (integrin, CD49e),
L (integrin, CD11a), β1 (integrin, CD29), β2 (integrin, CD18),
4β7 (integrin, LPAM-1), PSGL-1 (P-selectin ligand, CD162), and CCR9 (the CCL25 chemokine receptor). The data in Fig. 7 reveal a difference between CD25– and CD25+ subsets within the Thy1.2+ progenitor pool. Most CD25+ precursors expressed
4β1 (the VCAM-1 receptor),
5β1 (which binds fibronectins like
4β1),
Lβ2 (LFA-1, the receptor for ICAM-1 and ICAM-2),
4β7 (the receptor for MadCAM-1) and PSGL-1 described as also being expressed by TN2 thymocytes (31). However, CCR9 was rare on CD25+ cells and present on
30% of CD25– cells, whereas pre-T cells in the blood (16) and CLP-1 and CLP-2 cells in the BM were shown to be CCR9+ (30). Indeed, among Lin– Thy1.2+ splenic progenitors,
10% of CCR9+ cells were detected in B6 and nude mice, always in the CD25– subsets (Fig. 5D). Strikingly, the situation was different in the blood. Abundant CCR9+ progenitors were present in the blood of B6 mice but they were very rare among nude circulating progenitors (Fig. 5D). Thus, CCR9+ cells are probably retained in the spleen in the absence of a thymus and "called to circulate" by the thymus itself.
|
| Discussion |
|---|
|
|
|---|
+Sca-1+. It differentiates transiently in the thymus and produces only mature T cells following an i.v. graft. This splenic pre-T population expresses
4β1,
5β1,
Lβ2,
4β7, and PSGL-1, indicating a capacity to circulate, and to colonize the thymus and the gut. We demonstrate that the incidence of splenic pre-T cells is negatively regulated by the graft of B6 mature T cells (but not IL-7R
–/– T cells). Hence, Lin–Thy1.2+ pre-T cells are IL-7 dependent and under the control of the thymus and mature T cells. Moreover, we have identified a Lin–Thy1.2+ CD25+ c-kitlow subset in the spleen of nude mice, which contains the full pre-T cell potential and proliferation capacity. This latter population accumulates in the spleen of B6 mice after Tx, suggesting that this pre-T subset might be indeed able to colonize the thymus.
Phenotypic studies of Thy1, c-kit, and Sca-1 expression revealed that the pre-T cells we have identified in the spleen resemble the pre-T population we characterized after BM graft in spleen colonies (SC12) (18, 19). Moreover, these markers are present with the same intensity on pre-T cells from the BM (15, 32) and from adult (16) and fetal blood (23), suggesting that they are stable markers for this lineage. In contrast, IL-7R
and CD44 are expressed in a steady state but not after BM graft, indicating that these receptors could be modulated over the course of differentiation into pre-T cells. Antigenic modulation could be organ-specific, indeed, CCR9+ Lin–Thy1.2+ progenitors are abundant in the blood of B6 mice but rare on nude circulating cells. In contrast, CCR9+ progenitors are retained in the spleen in the absence of a thymus.
Intrathymic differentiation proceeds according to four major differentiation steps defined by CD44/CD25 expression. Expression of CD25 on the splenic pre-T population indicates that the latter enters the thymus at the DN2 stage. In addition to its phenotypic characteristics (CD44, CD25, IL-7R
, and Thy1 expression), its hemopoietic potential and molecular profile (data not shown) resemble those of TN2 cells. Indeed, less specialized progenitors probably enter at the DN1 stage; once in the niches, they receive the appropriate molecules for driving T cell differentiation. NK development is repressed by Notch signaling prior to the DN2 stage (33) and thus only the T cell potential is retained. This mechanism is confirmed by our culture of splenic Lin–Thy1.2+ cells on an OP9-DL1 stroma, on which the NK potential is considerably repressed (Fig. 4). However, we succeed in purifying a population exclusively restricted to the T cell lineage within the CD25+ c-kitlow subset, suggesting that it is the latter that migrates to the thymus (Fig. 5). In addition to Notch signals, numerous molecular events take place from TN2 stage on: Pu1 is one of the genes shut off at this transition and Gata3 and the E protein/Id ratio seem to be essential for T cell specification (Ref. 34 and our unpublished data). Hence, identification of the cascade of molecular events driven by, to date, undefined signals will be of major importance.
In terms of other T cell precursors reported outside the thymus, a Lin–Thy1.2highCD44highCD25– population isolated from the BM of B6 mice was shown to generate only T cells through an extrathymic pathway, although in vitro studies on an OP9 stroma were not performed (15). However, the BM counterpart in the nude mouse was unable to generate T cells in vivo, probably due to a BM defective stroma, as suggested by the authors (32). In contrast, we demonstrated that the pre-T population in nude spleen is able to reconstitute the T cell compartment efficiently. Thus, in nude mice, T cell commitment is absent in the BM (because of a defective stroma) but always occurs in the spleen, suggesting that the microenvironment and an appropriate signal density (Delta-1 and Delta-4 ligands are expressed by stromal cells in the spleen; our unpublished observations) are maintained. Interestingly, both splenic and medullary pre-T cells are under the control of mature T cells. The maturation of the BM T cell precursors is arrested in vitro by coculture with mature T cells (35), and we have shown that the splenic pre-T population is negatively regulated in vivo by mature T cells via the uptake of IL-7. This inhibitory feedback prevents BM pre-T cell maturation and splenic pre-T cell expansion/survival. Hence, T cell precursors are tightly controlled. Thus, although DN populations are in charge of controlling the entry of progenitors (2), more mature T cells are responsible for the homeostatic regulation of progenitors in the periphery (this work and Ref. 13).
Very recently, another pre-T population has been described in the blood (16). Phenotypic and functional analogies between this latter population, the CTP in the BM and splenic pre-T cells suggest that all three populations might belong to a common pathway (Table III). These studies demonstrate that T cell commitment (characterized by Thy1 up-regulation) can occur in the BM and in the spleen. These pre-T populations can recirculate in the blood and colonize the thymus and the gut. The location-specific characteristics of the pre-T populations identify major markers that will help establish the different steps in the pre-T lineage.
|
| Acknowledgments |
|---|
–/– mice. | Disclosures |
|---|
|
|
|---|
| Footnotes |
|---|
1 L.G. and M.-L.A. were supported by the Ministère de la Recherche et de la Technologie and by the Association de la Recherche sur le Cancer. This project was supported by the Institut National de la Santé et de la Recherche Médicale, Association de la Recherche sur le Cancer and the Action Concertée Thématique sur les Cellules Souches Adultes (sponsored by the Institut National de la Santé et de la Recherche Médicale, Association Française des Myopathies, Vaincre la Mucoviscidose, Juvenil Diabetes Research Foundation, Ministère de la Jeunesse, de lEducation et de la Recherche) to S.E. ![]()
2 Address correspondence and reprint requests to Dr. Sophie Ezine, Institut National de la Santé et de la Recherche Médicale U591, Institut Necker, Université Paris V, 156 rue de Vaugirard, Paris, France. E-mail address: ezine{at}necker.fr ![]()
3 Abbreviations used in this paper: BM, bone marrow; DN, double negative; i.t., intrathymic(cally); wt, wild type; LSK, Lin–Sca-1+ c-kit+; CLP, common lymphoid progenitor; ETP, earliest T cell progenitor; CTP, committed T cell population; IEL, intraepithelial lymphocyte; Tx, thymectomized; LN, lymph nodes; TN, triple negative; DP, double positive. ![]()
Received for publication February 15, 2007. Accepted for publication June 22, 2007.
| References |
|---|
|
|
|---|
-like-1 in vitro. Immunity 17: 749-756. [Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |